JBIR-23 and -24, novel anticancer agents from Streptomyces sp. AK-AB27

Org Lett. 2009 Jan 15;11(2):285-8. doi: 10.1021/ol802611w.

Abstract

The screening for active compounds against malignant pleural mesothelioma (MPM) cells produced by Streptomyces sp. AK-AB27 resulted in the isolation of two compounds with a dodecahydrodibenzo[b,d]furan skeleton named JBIR-23 (1) and -24 (2). Their structures were established on the basis of extensive NMR and MS analyses. Compounds 1 and 2 exhibited cytotoxic effects against several MPM cell lines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / isolation & purification*
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Benzofurans / chemistry
  • Benzofurans / isolation & purification*
  • Benzofurans / pharmacology*
  • Benzofurans / therapeutic use
  • Cell Line, Tumor
  • Drug Evaluation, Preclinical
  • Humans
  • Mesothelioma / drug therapy
  • Streptomyces / chemistry*
  • Streptomyces / classification

Substances

  • Antineoplastic Agents
  • Benzofurans
  • JBIR-23
  • JBIR-24